DAFNA Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

DAFNA Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-39,704	Closed	-$1.81M	–	77
2016 Q3	$1.81M	Hold	39,704	–	–	1.26%	27
2016 Q2	$1.59M	Hold	39,704	–	–	1.26%	25
2016 Q1	$1.38M	Buy	+39,704	New	+$1.46M	1.19%	25
2015 Q1	–	Sell	-33,466	Closed	-$1.29M	–	79
2014 Q4	$1.29M	Sell	33,466 -26,588	-44%	-$1.01M	1.02%	27
2014 Q3	$2.12M	Sell	60,054 -10,034	-14%	-$295K	2.14%	14
2014 Q2	$1.89M	Hold	70,088	–	–	1.79%	14
2014 Q1	$1.82M	Buy	70,088 +18,396	+36%	+$441K	1.56%	16
2013 Q4	$1.12M	Hold	51,692	–	–	1.15%	18
2013 Q3	$1.01M	Hold	51,692	–	–	1.1%	22
2013 Q2	$806K	Buy	+51,692	New	+$832K	1.18%	23

Other funds holding BSTC

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

DAFNA Capital Management's BSTC Position: Q4 2016 in Review

DAFNA Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2016, closing a stake of 39,704 shares — an estimated $1.81M sold.

DAFNA Capital Management first reported a position in BSTC in Q2 2013 and held it in 10 quarters. The position peaked at $2.12M in Q3 2014. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

DAFNA Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2016 after selling out during the quarter.
DAFNA Capital Management sold 39,704 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $1.81M.
DAFNA Capital Management first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 10 quarters.
DAFNA Capital Management's BioSpecifics Technologies Corp. position peaked at $2.12M in Q3 2014.
96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on DAFNA Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.